Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.
Stevens, D R
Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Aug 2015 - 625-6 p. digital
Publication Type: Letter; Comment
1399-3062
10.1111/tid.12396 doi
Allografts--virology
Antiviral Agents--administration & dosage
Cytomegalovirus Infections--prevention & control
Female
Ganciclovir--analogs & derivatives
Graft Rejection--prevention & control
Humans
Immunosuppressive Agents--adverse effects
Kidney Failure, Chronic--surgery
Kidney Transplantation
Male
Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Aug 2015 - 625-6 p. digital
Publication Type: Letter; Comment
1399-3062
10.1111/tid.12396 doi
Allografts--virology
Antiviral Agents--administration & dosage
Cytomegalovirus Infections--prevention & control
Female
Ganciclovir--analogs & derivatives
Graft Rejection--prevention & control
Humans
Immunosuppressive Agents--adverse effects
Kidney Failure, Chronic--surgery
Kidney Transplantation
Male